ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Deprivation, Hot Flashes, and Recovery: Localized Prostate Cancer Patients
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 93524" data-attributes="member: 2624"><p>Androgen deprivation, also known as "chemical castration," is a treatment modality utilized in some cases of prostate cancer. <em>It should be noted that what the authors of this study characterize as "recovery" in regard to testosterone levels is - frankly - absurd.</em></p><p><em></em></p><ul> <li data-xf-list-type="ul">This study describes the proportion of men who experienced hot flashes (flashes), and the testosterone level at onset, peak frequency and cessation of flashes after 12 months of androgen deprivation therapy (ADT) in men undergoing curative-intent external beam radiation therapy (± brachytherapy boost). We also aimed to characterise testosterone recovery in this population.</li> <li data-xf-list-type="ul">The median age and follow-up were 68 years and 6.1 years.</li> <li data-xf-list-type="ul">Flashes were reported in 93% of men.</li> <li data-xf-list-type="ul">Flashes began and reached peak frequency at a median time of 4.0 months from the first luteinizing hormone-releasing hormone injection when testosterone levels had fallen to castrate.</li> <li data-xf-list-type="ul">The median time to cessation of flashes was 7.6 months after the cessation of ADT (last injection + 3 months), when the median testosterone had risen to 5.7 nmol/l.</li> <li data-xf-list-type="ul">A resolution of flashes was reported in 99% of patients.</li> <li data-xf-list-type="ul">Baseline testosterone was available in 338 patients (85%).</li> <li data-xf-list-type="ul">The median baseline testosterone was 13.2 nmol/l.</li> <li data-xf-list-type="ul">The median (95% confidence interval) time of testosterone recovery to thresholds of 5 nmol/l, 7.5 nmol/l and 10 nmol/l were 9 (9-10) months, 13 (10-15) months and 18 (17-19) months from the cessation of ADT.</li> <li data-xf-list-type="ul">At the time of censor, 96, 94 and 91% of patients had recovered testosterone to thresholds of 5, 7.5 and 10 nmol/l.</li> </ul><p><strong>"The Relationship between Hot Flashes and Testosterone Recovery after 12 Months of Androgen Suppression for Men with Localised Prostate Cancer in the ASCENDE-RT Trial," </strong><em>Clinical Oncology, </em>2017 October 29, <a href="https://www.ncbi.nlm.nih.gov/pubmed/28712786/" target="_blank">https://www.ncbi.nlm.nih.gov/pubmed/28712786/</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 93524, member: 2624"] Androgen deprivation, also known as "chemical castration," is a treatment modality utilized in some cases of prostate cancer. [I]It should be noted that what the authors of this study characterize as "recovery" in regard to testosterone levels is - frankly - absurd. [/I] [LIST] [*]This study describes the proportion of men who experienced hot flashes (flashes), and the testosterone level at onset, peak frequency and cessation of flashes after 12 months of androgen deprivation therapy (ADT) in men undergoing curative-intent external beam radiation therapy (± brachytherapy boost). We also aimed to characterise testosterone recovery in this population. [*]The median age and follow-up were 68 years and 6.1 years. [*]Flashes were reported in 93% of men. [*]Flashes began and reached peak frequency at a median time of 4.0 months from the first luteinizing hormone-releasing hormone injection when testosterone levels had fallen to castrate. [*]The median time to cessation of flashes was 7.6 months after the cessation of ADT (last injection + 3 months), when the median testosterone had risen to 5.7 nmol/l. [*]A resolution of flashes was reported in 99% of patients. [*]Baseline testosterone was available in 338 patients (85%). [*]The median baseline testosterone was 13.2 nmol/l. [*]The median (95% confidence interval) time of testosterone recovery to thresholds of 5 nmol/l, 7.5 nmol/l and 10 nmol/l were 9 (9-10) months, 13 (10-15) months and 18 (17-19) months from the cessation of ADT. [*]At the time of censor, 96, 94 and 91% of patients had recovered testosterone to thresholds of 5, 7.5 and 10 nmol/l. [/LIST] [B]"The Relationship between Hot Flashes and Testosterone Recovery after 12 Months of Androgen Suppression for Men with Localised Prostate Cancer in the ASCENDE-RT Trial," [/B][I]Clinical Oncology, [/I]2017 October 29, [URL]https://www.ncbi.nlm.nih.gov/pubmed/28712786/[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Deprivation, Hot Flashes, and Recovery: Localized Prostate Cancer Patients
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top